Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!

 



Forgot your password?
typodupeerror
×
Mozilla

Submission + - MORE than a fifth of Australians now use Firefox

nermaljcat writes: Australian IT reports that 22% of Australians are now using Firefox. Internet Explorer still claims 81% of the market, but that also includes Firefox users (like myself) that occasionally need to use IE because of compatibility issues with some websites.

"MORE than a fifth of Australians now use the Mozilla Firefox web browser, even though site compatibility issues mean it sometimes must be used in conjunction with Microsoft's Internet Explorer, researcher Nielsen Net Ratings says."
Biotech

Submission + - Scientists Cure Cancer - No One Notices

Messianni writes: "A report at New Scientist has an article claiming that scientists have found a cheap, already tested drugs that kills most cancers. From the article:
"It sounds almost too good to be true: a cheap and simple drug that kills almost all cancers by switching off their "immortality". The drug, dichloroacetate (DCA), has already been used for years to treat rare metabolic disorders and so is known to be relatively safe. It also has no patent, meaning it could be manufactured for a fraction of the cost of newly developed drugs.
DCA attacks a unique feature of cancer cells: the fact that they make their energy throughout the main body of the cell, rather than in distinct organelles called mitochondria. This process, called glycolysis, is inefficient and uses up vast amounts of sugar. Until now it had been assumed that cancer cells used glycolysis because their mitochondria were irreparably damaged. However, Michelakis's experiments prove this is not the case, because DCA reawakened the mitochondria in cancer cells. The cells then withered and died."
So where is this in the rest of the media? Are the drug companies that powerful?"

Slashdot Top Deals

The rule on staying alive as a forecaster is to give 'em a number or give 'em a date, but never give 'em both at once. -- Jane Bryant Quinn

Working...